Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/21/2011 | EP2077111B1 Antidepressant agent |
12/21/2011 | EP2069346B1 Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof |
12/21/2011 | EP2026803B1 Compositions of r(+) and s(-) pramipexole and methods of using the same |
12/21/2011 | EP1966156B1 New compounds iii |
12/21/2011 | EP1966139B1 Aspartic protease inhibitors |
12/21/2011 | EP1944029B1 Pharmaceutical preparation having excellent photostability |
12/21/2011 | EP1937232B1 Nutraceutical composition for the treatment of muscle wasting |
12/21/2011 | EP1934227B1 2-HETEROARYL-PYRAZOLO-[4, 3-e]-1, 2, 4-TRIAZOLO-[1,5-c]-PYRIMIDINE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
12/21/2011 | EP1926729B1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands |
12/21/2011 | EP1888074B1 Agent for the prevention and treatment of liver diseases containing pyrazolopyrimidine derivative |
12/21/2011 | EP1880995B1 Method for producing indole derivative having piperidine ring |
12/21/2011 | EP1863469B1 A topical analgesic composition |
12/21/2011 | EP1838709B1 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-infective agents |
12/21/2011 | EP1833836B1 Imidazo-fused thiazolo [4,5-b] pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
12/21/2011 | EP1832584B1 Pyrimidinylisoxazole derivative |
12/21/2011 | EP1809329B1 Sustained local anesthetic composition containing saib |
12/21/2011 | EP1804789B1 Method of treating human preeclampsia employing resibufagenin |
12/21/2011 | EP1799691B1 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors |
12/21/2011 | EP1774968B1 Psycothropic agent and health food containing neferine |
12/21/2011 | EP1763350B1 Nicotinamide derivatives and their use as therapeutic agents |
12/21/2011 | EP1750770B1 Use of organo-silicon compounds for constraining connective damaged tissues |
12/21/2011 | EP1689724B1 Quinazolinone compounds as anticancer agents |
12/21/2011 | EP1663971B1 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
12/21/2011 | EP1656157B1 2-methylene-19-nor-vitamin d2 compounds |
12/21/2011 | EP1644008B1 Continuous dosing regimen with abt-751 |
12/21/2011 | EP1638551B1 Immunosuppressant compounds and compositions |
12/21/2011 | EP1599443B1 Cycloalkyl-substituted alkanoic acid derivatives, methods for the production thereof, and use thereof as a medicament |
12/21/2011 | EP1534290B1 Novel inhibitors of kinases |
12/21/2011 | EP1507855B1 Elongase genes and uses thereof |
12/21/2011 | EP1454142B1 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
12/21/2011 | EP1381367B1 Aripiprazole oral solution |
12/21/2011 | EP1326841B1 Pyridinone derivatives for treatment of atherosclerosis |
12/21/2011 | EP1266003B1 Kcnb: a potassium channel protein |
12/21/2011 | EP1158959B1 Compositions and methods for improved delivery of hydrophobic therapeutic agents |
12/21/2011 | EP0852581B1 Preparation of taxol and docetaxel through primary amines |
12/21/2011 | EP0836506B2 Transdermal patch for administering 17-deacetyl norgestimate in combination with an estrogen |
12/21/2011 | EP0734249B3 Novel and improved aminoglycoside formulation for aerosolization |
12/21/2011 | CN1997369B 阿片样受体拮抗剂化合物在制备治疗和/或预防对抑制靶向钙调神经磷酸酶敏感的皮肤病的药物中的应用 Preparation of opioid receptor antagonist treatment and / or prevention of the targeted inhibition of the enzyme calcineurin-sensitive dermatological medicament compound |
12/21/2011 | CN1980677B 靶向兰诺定受体(ryr2)渗漏的新颖抗心律失常和心力衰竭药物及其应用 Targeting ryanodine receptor (ryr2) leakage novel antiarrhythmic drugs and heart failure and its application |
12/21/2011 | CN1968946B 苯并咪唑酮羧酸衍生物 Benzimidazol-carboxylic acid derivatives |
12/21/2011 | CN1946716B 含有氰基吡咯的环状氨基甲酸酯和硫代氨基甲酸酯联芳基以及其制备方法 Cyclic carbamate and thiocarbamate biaryls cyano group-containing pyrrole and their preparation |
12/21/2011 | CN1942439B 无定形形式的阿托伐他汀钙的制备方法 The amorphous form of atorvastatin calcium preparation |
12/21/2011 | CN1876003B 白首乌有效部位的制备方法及其在治疗失眠药物中的用途 Preparation Baishouwu effective part of their use in the treatment of insomnia drug |
12/21/2011 | CN1845738B 适于兽医和医疗应用的组合物 Compositions suitable for veterinary and medical applications |
12/21/2011 | CN1738817B 玻璃体结合蛋白受体的新的拮抗剂衍生物,它们的制备方法,它们作为药物的应用和包含它们的药物组合物 Vitronectin receptor antagonists new derivatives, processes for their preparation, their use as medicaments and pharmaceutical compositions containing them |
12/21/2011 | CN1685063B 与基因沉默相关的方法和组合物 Associated with gene silencing methods and compositions |
12/21/2011 | CN1650013B 抗汉坦病毒属病毒感染的dna疫苗 Anti-hantavirus infection dna vaccine |
12/21/2011 | CN102292443A 使用短干扰核酸(siNA)的RNA干扰介导的上皮钠通道(ENaC)基因表达的抑制 Inhibition using short interfering nucleic acid (siNA) of RNA interference mediated epithelial sodium channel (ENaC) gene expression |
12/21/2011 | CN102292341A 对apo a有活性的噻吩并三唑并二氮杂*衍生物 Active against apo a thieno-triazolo-diaza derivative * |
12/21/2011 | CN102292340A 用作pde9 抑制剂的氨基-杂环类化合物 Amino used as pde9 inhibitors - heterocyclic compounds |
12/21/2011 | CN102292339A 作为MetAP-2抑制剂的新杂环化合物 As a new heterocyclic compound MetAP-2 inhibitor |
12/21/2011 | CN102292337A 螺吲哚满酮衍生物前药 Spiro indolinone derivative prodrugs |
12/21/2011 | CN102292336A 二氮杂二环壬基嘧啶衍生物的n-氧化物及它们的医药用途 N- oxide diazabicyclo nonyl pyrimidine derivatives and their pharmaceutical use |
12/21/2011 | CN102292335A (2s,3r)-n-2-((3-吡啶基)甲基)-1-氮杂双环[2.2.2]辛-3-基)-3,5-二氟苯甲酰胺的制备和治疗应用 (2s, 3r) -n-2 - ((3- pyridinyl) methyl) -1-azabicyclo [2.2.2] oct-3-yl) -3,5-difluorophenyl-carboxamide and therapeutic use |
12/21/2011 | CN102292333A 蛋白激酶c抑制剂及其用途 C protein kinase inhibitors and their use |
12/21/2011 | CN102292332A 5-氯-n-{[(5s)-2-氧代-3-[4-(3-氧代吗啉-4-基)苯基]噁唑烷-5-基]-甲基}噻吩-2-甲酰胺的多晶型物 5-chloro -n - {[(5s) -2- oxo-3- [4- (3-oxo-morpholin-4-yl) phenyl] oxazolidin-5-yl] - methyl} thiophene 2-carboxamide polymorph |
12/21/2011 | CN102292329A 布鲁顿酪氨酸激酶的抑制剂 Bruton tyrosine kinase inhibitors |
12/21/2011 | CN102292328A 具有cb2受体激动活性的n-取代饱和杂环砜化合物 Agonistic activity n- receptor having cb2 substituted saturated heterocyclic sulfone compound |
12/21/2011 | CN102292323A 芳基甲基苯并喹唑啉酮m1受体正向变构调节剂 Aryl methylbenzo -quinazolinon m1 receptor positive allosteric modulator |
12/21/2011 | CN102292322A 用于治疗例如癌症的疾病的取代的嘧啶 Substituted pyrimidines for the treatment of diseases such as cancer |
12/21/2011 | CN102292321A 作为前列环素(pgi2)受体调节剂用于治疗该受体相关病症的吡唑基取代的碳酸衍生物 Carbonic acid derivatives as prostacyclin (pgi2) receptor modulators for the treatment of the receptor-associated disorder substituted pyrazole |
12/21/2011 | CN102292320A 作为glyt-1抑制剂的芳酰基氨基-和杂芳酰基氨基-取代的哌啶类 As glyt-1 inhibitors aroylamino - and heteroaryl acylamino - substituted piperidines |
12/21/2011 | CN102292319A 作为钙通道阻滞剂的取代八氢环戊二烯并(c)吡咯-4-胺 As calcium channel blockers substituted octahydro-cyclopenta (c) pyrrole-4-amine |
12/21/2011 | CN102292316A 胰高血糖素拮抗剂 Glucagon antagonists |
12/21/2011 | CN102292109A 用于治疗耐受性癌症的聚合物胶束组合物及其制备方法 Polymeric micelle composition and preparation methods for the treatment of cancer tolerance |
12/21/2011 | CN102292108A 包括甲胺喋呤以及二氢乳清酸脱氢酶抑制剂的组合 Include a combination of methotrexate and methylamine DHODH inhibitors |
12/21/2011 | CN102292091A 用于预防和治疗动脉硬化的组合物 Compositions for the prevention and treatment of atherosclerosis |
12/21/2011 | CN102292090A 用于激活线粒体的组合物 Compositions for activating mitochondrial |
12/21/2011 | CN102292089A 改善的用于人乳头状瘤病毒的疫苗及其使用方法 Improved vaccine for human papilloma virus and methods of use |
12/21/2011 | CN102292088A 普利醇纳米粒子 Policosanol nanoparticles |
12/21/2011 | CN102292087A 使用夫西地酸钠和类固醇制备的新型皮肤用乳膏 Using sodium fusidate and steroid novel skin creams prepared |
12/21/2011 | CN102292086A 药物组合物 The pharmaceutical composition of |
12/21/2011 | CN102292085A 包含氨氯地平和氯沙坦的固体药物组合物及其制备方法 Solid pharmaceutical composition and preparation method contains amlodipine losartan |
12/21/2011 | CN102292084A 包含氨氯地平和氯沙坦的固体药物组合物 Contains amlodipine and losartan solid pharmaceutical composition |
12/21/2011 | CN102292083A 包括7-羟基-苯并咪唑-4-基-甲酮衍生物的糖原合酶激酶-3β抑制剂 Including 7-hydroxy - benzimidazole-4-yl - methanone derivatives glycogen synthase kinase -3β inhibitor |
12/21/2011 | CN102292082A 对抗环境应激作用、提高免疫和改善精力同时解决维生素和矿物质缺乏且不具有大剂量的营养补充剂的副作用的多种维生素/矿物质制剂 Against environmental stress, and improve immunity and improve energy while addressing vitamin and mineral deficiencies and does not have a large dose of multivitamin supplements side effects / mineral preparations |
12/21/2011 | CN102292081A 包含硫辛酸和羟基柠檬酸作为活性成分的药物联用物 Contains lipoic acid and hydroxy citric acid as an active ingredient thereof in combination with |
12/21/2011 | CN102292080A 使用夫西地酸钠、抗真菌药和类固醇制备的新型皮肤用乳膏 Use fusidate sodium novel antifungal and steroid skin creams prepared |
12/21/2011 | CN102292079A 包含头孢洛林的组合物和治疗方法 The compositions and methods of treatment include cephalosporins Lorraine |
12/21/2011 | CN102292078A 哺乳动物雷帕霉素靶蛋白的抑制 Inhibition of the mammalian target of rapamycin |
12/21/2011 | CN102292075A 包含hcv聚合酶抑制剂前药的药物组合物 Hcv polymerase inhibitors prodrug comprising a pharmaceutical composition |
12/21/2011 | CN102292074A 包含阿格列扎的药物组合物 The pharmaceutical composition comprising aleglitazar |
12/21/2011 | CN102292073A 苯达莫司汀的固体剂型 Bendamustine solid dosage forms |
12/21/2011 | CN102292071A 包含2-氧代-1-吡咯烷衍生物的药物组合物 Containing 2-oxo-1-pyrrolidine derivatives of pharmaceutical compositions |
12/21/2011 | CN102292070A 具有提高的稳定性的包含氨氯地平和氯沙坦的固体药物组合物 Having improved stability of a solid pharmaceutical composition comprising amlodipine and losartan |
12/21/2011 | CN102292069A 囊泡制剂 Vesicle preparation |
12/21/2011 | CN102292068A 双氯芬酸、卡马西平和苄达明的透皮递送 Diclofenac, carbamazepine and benzydamine transdermal delivery |
12/21/2011 | CN102291997A 包含瓜尔胶的饼干 Biscuits containing guar gum |
12/21/2011 | CN102291995A 动物饲料添加剂与含有中链脂肪酸烷基酯的动物饲料以及它们在动物饲料中的应用 Animal feed additives and animal feeds containing medium chain fatty acid alkyl esters and their use in animal feed |
12/21/2011 | CN102291992A 同期发情制剂和有效的无cidr方案 Estrus synchronization and effective preparation program without cidr |
12/21/2011 | CN102291991A 用于治疗分枝杆菌的多重耐药和广泛耐药菌株的抗菌分子 Antimicrobial molecules for the treatment of multidrug-resistant and extensively drug-resistant Mycobacterium strains |
12/21/2011 | CN102288601A 一种肌球蛋白atp酶活性微量测定方法及其应用 One kind of myosin activity atp trace measurement method and its application |
12/21/2011 | CN102286109A 一种螺旋藻活性多糖及其制备方法 An active Spirulina polysaccharide and its preparation method |
12/21/2011 | CN102286066A 6-氧代-7-氧杂-B-Homo-胆甾-3-缩氨硫酰腙化合物的制备方法及其在抗肿瘤药物中的应用 6-oxo-7-oxa -B-Homo- cholesteric preparation -3- reduction of ammonia and sulfur compounds acylhydrazone application of anticancer drugs |
12/21/2011 | CN102286065A 新型松香烷型二萜衍生物、其制备方法和应用 The new diterpene rosin derivatives, their preparation and use |
12/21/2011 | CN102286064A 具有胰岛素增敏活性的化合物及其制备方法和用途 Have insulin-sensitizing activity of compounds and their preparation and use |
12/21/2011 | CN102286057A 齐墩果烷型三帖类化合物及其制备方法和医疗用途 Oleanane type triterpenes compound and its preparation method and medical use |
12/21/2011 | CN102286056A 一种齐墩果酸衍生物及其制备方法 One kind of oleanolic acid derivatives and preparation method |
12/21/2011 | CN102286055A B-降-3,6-二取代胆甾烷化合物及其制备方法和在制备抗肿瘤药物中的应用 B- drop cholestane-3,6-di-substituted compound and its preparation method and application in the preparation of anticancer drugs |
12/21/2011 | CN102286054A Cyclovirobuxinum D derivatives and preparation method and use thereof |